Search

Search Constraints

You searched for: Issue Volume 16:Issue 12(2020)

Search Results

197. Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer. Issue 12 (1st December 2020)